Key Market Indicator:
Stock market news: In short news style a la Twitter/X. Everything that is relevant - at a glance. The entry page for the informed investor. Compact, worth knowing and always up to date. Directly from the IR departments of the companies.
Tue, 01.10.2024
Lonza Group AG
Lonza Group AG
/ Key word(s): Acquisition
Lonza Completes Acquisition of Large-Scale Biologics Site in Vacaville (US) from Roche 01.10.2024 / 16:45 CET/CEST
The Vacaville site is one of the largest biologics manufacturing facilities in the world
Acquisition extends Lonza’s US Biologics footprint with a significant presence on [ … ]
Tue, 01.10.2024
Mutares SE & Co. KGaA
Fifth exit in 2024: Mutares has signed an agreement to sell MobiLitas to Savina for a purchase price in the single-digit million range
Munich, October 1, 2024 – Mutares SE & Co. KGaA (ISIN: DE000A2NB650) has signed an agreement to sell MobiLitas to Savina, a local successful entrepreneur, for an equity purchase price in the single million digi [ … ]
Tue, 01.10.2024
Alzchem Group AG
Alzchem Group AG set to join the SDAX on October 2, 2024
Trostberg, October 1, 2024 – Alzchem Group AG, a vertically integrated specialty chemicals supplier with a leading market position in selected niche markets, will be included in the SDAX selection index for the first time on October 2, 2024. This makes Alzchem one of the 160 largest and most [ … ]
Tue, 01.10.2024
Springer Nature AG & Co. KGaA
NOT FOR DISTRIBUTION OR RELEASE, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, CANADA, AUSTRALIA OR JAPAN OR ANY OTHER JURISDICTION IN WHICH THE DISTRIBUTION OR RELEASE WOULD BE UNLAWFUL. OTHER RESTRICTIONS ARE APPLICABLE. PLEASE SEE THE IMPORTANT NOTICE AT THE END OF THIS PRESS RELEASE.PRESS RELEASE Final offer price for Springer Nature sh [ … ]
Tue, 01.10.2024
Springer Nature AG & Co. KGaA
AD HOC RELEASE PUBLICATION OF INSIDE INFORMATION BY WAY OF AD HOC DISCLOSURE PURSUANT TO ARTICLE 17 OF THE REGULATION (EU) NO 596/2014 NOT FOR DISTRIBUTION OR ANNOUNCEMENT, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES OF AMERICA, AUSTRALIA, CANADA, JAPAN, SOUTH AFRICA OR ANY OTHER JURISDICTION IN WHICH THE DISTRIBUTION OR ANNOUNCEMENT WOULD [ … ]
Tue, 01.10.2024
KAP AG
KAP AG STREAMLINES INVESTMENT PORTFOLIO AND SELLS PRECISION COMPONENTS SEGMENT
The aim of the sale is to sharpen the strategic focus through further portfolio optimisation
Transaction planned to be closed by end of October 2024
Fulda, 1 October 2024 – KAP AG (“KAP”), a mid-sized industrial holding company listed on the stock exchange (German s [ … ]
Tue, 01.10.2024
KAP AG
KAP AG STREAMLINES INVESTMENT PORTFOLIO AND SELLS PRECISION COMPONENTS SEGMENT
Fulda, 1 October 2024 – KAP AG (“KAP”), a mid-sized industrial holding company listed on the stock exchange (German securities identification number WKN 620840, ISIN DE0006208408), today concluded an agreement on the sale of all material parts of the precision component [ … ]
Tue, 01.10.2024
Heidelberg Pharma AG
Ad hoc announcement
Disclosure of inside information under Article 17 of Regulation (EU) No 596/2014
Heidelberg Pharma AG Announces Updated Guidance
Ladenburg, Germany, 1 October 2024 – Heidelberg Pharma AG (FSE: HPHA), a clinical stage biotech company developing innovative Antibody Drug Conjugates (ADCs), today announces that it has adjusted it [ … ]
Tue, 01.10.2024
Laxxon Medical
Laxxon Medical and Adare Pharma Solutions Announce Joint Cooperation for Production of cGMP 3D Printed Oral Dosage Forms in Europe and US New York, 10/01/2024 / 09:00, EST/EDT - EQS Newswire - Laxxon Medical
Laxxon Medical, a leading pharma-technology company pioneering a new generation of advanced oral drug delivery systems, and Adare Ph [ … ]
Tue, 01.10.2024
Mainz BioMed N.V.
Mainz Biomed Publishes CEO Statement; CEO Guido Baechler Eyes Major Growth and U.S. FDA Trials in 2025
BERKELEY, US and MAINZ, Germany – October 1, 2024 -- Mainz Biomed N.V. (NASDAQ:MYNZ) (“Mainz Biomed” or the “Company”), a molecular genetics diagnostic company specializing in the early detection of cancer, today released a statement to sharehold [ … ]